Categories
Business

Volvo Plans to Promote Solely Electrical Automobiles by 2030

Volvo Cars announced that it will switch its entire product range to battery power by 2030 and retire vehicles with internal combustion engines faster than other automakers such as General Motors.

Sweden-based Volvo and owned by Geely Holding of China has prevailed over larger competitors in switching to electric power. In 2019, all models sold were either hybrids or run on batteries only.

By 2030, Volvo said in a statement on Tuesday, it will “phase out every car in its global portfolio with an internal combustion engine, including hybrids.”

While hybrids are more fuel efficient than traditional vehicles, they may not be much better for urban climate or air quality if drivers don’t use the electrical capabilities.

GM’s promise to sell only zero-emission vehicles, which it made in January, won’t take effect until 2035.

Volvo admitted to responding in part to pressure from governments, many of which have announced internal combustion engine bans in the coming years.

The company said its decision was based on the expectation that legislation and rapid expansion of accessible high-quality charging infrastructure will accelerate consumer adoption of all-electric cars.

In another break with industrial practice, Volvo’s electric models are sold exclusively online, bypassing dealerships.

“Instead of investing in a shrinking business, we are investing in the future – electric and online,” said Hakan Samuelsson, Volvo’s general manager, in a statement.

Categories
Business

Chinese language electrical automobile start-up Li Auto expects to promote fewer than Nio

A Li Xiang One Hybrid SUV is on display during the 18th Guangzhou International Auto Show in Guangzhou, China on Nov 23, 2020.

Li Zhihao | Visual China Group | Getty Images

BEIJING – Chinese automaker Li Auto, listed on the Nasdaq, is forecasting deliveries in the first quarter that will be below those of its competitors.

Li Auto announced late Thursday that it is expected to deliver between 10,500 and 11,500 cars, or fewer than 4,000 vehicles per month, for the first quarter of the year. Shares fell 9.8% in the New York trading session on a wider market sell-off. The stock lost another 3.75% in over-the-counter trading.

Nio, which competes directly with Li Auto in the high-end SUV market, shipped more than 7,000 units in both December and January. The company will release its latest financial report on Monday.

Xpeng shipped 5,700 cars in December and more than 6,000 in January.

Although the numbers of startups suggest rapid growth, they still pale in comparison to Tesla. Elon Musk’s electric car company shipped nearly half a million vehicles worldwide last year, which is an average of more than 41,000 cars per month.

Despite the New Year holiday in mid-February this year, Li Auto’s poor forecast is worrying, said Tu Le, founder of Beijing-based consulting firm Sino Auto Insights.

He pointed out that the company only has one product compared to the other startups and that it should deliver at least 5,000 to 7,000 vehicles a month to keep up.

Li Auto’s only vehicle, the Li One, is a hybrid electric vehicle equipped with a fuel tank to charge the battery.

Analysts have said the feature makes the Li One attractive to Chinese consumers who are concerned about running out of power without access to a charging station.

Last year, the Li One was one of the top 10 high-end SUVs sold in China, regardless of the fuel type, according to the passenger car association. However, the company announced that January shipments fell from 6,126 the previous month to 5,379 units.

The company reported total revenue of 4.15 billion yuan ($ 635.5 million) for the fourth quarter, compared with 2.51 billion yuan in the previous quarter.

Li Auto expects total sales for the first three months of this year to be in line with the last two quarters, with an expected range of 2.94 to 3.22 billion yuan.

Categories
Health

Three Males Are Accused in Scheme to Promote Covid-19 Vaccines

Three Baltimore men were accused by federal prosecutors of setting up a fake website to sell Covid-19 vaccines for $ 30 a dose.

The men, Olakitan Oluwalade, 22, and Odunayo Baba Oluwalade, 25, who are cousins, and Kelly Lamont Williams, 22, are charged with conspiracy for wire fraud, the US District Attorney’s Office said on Thursday.

Prosecutors said the men created a website similar to that of Moderna, the Cambridge, Massachusetts-based biotechnology company, which received federal approval in December to distribute its Covid-19 vaccine.

The real website is modernatx.com, and the website created by the men that authorities have since confiscated was modernatx.shop. Prosecutors said the fake domain’s source code revealed that the creator used a tool to copy the real Moderna website.

“The logo, the markings, colors and texts on the fake domain were visually similar,” said a statement from the company’s actual homepage. But prosecutors said the bogus website had an addition, “You might be able to purchase a COVID-19 vaccine in advance,” with a link to “Contact Us.”

The men were caught after an undercover agent contacted the number on the fake website on Jan. 11 and completed a transaction for 200 doses of the vaccine for $ 6,000. Officials said the three men never had any cans.

The agent was ordered to transfer half of the funds to Mr. Williams’ account with the Navy Federal Credit Union. By January 15, agents had confiscated the fake domain and ransacked Mr. Williams’ home.

Investigators found texts between Mr. Williams and the cousins ​​discussing the system, according to court documents.

An agent used Mr. Williams’ phone to send a message to Odunayo Baba Oluwalade and sent some of the money from the exchange to the cousins, prosecutors said. Her two houses were also soon searched.

It was unclear how much money the men had cheated. A spokeswoman for the US law firm said Friday that she could not provide any further details on the charges than stated in the statement.

A representative from Moderna could not be reached immediately on Friday.

A lawyer, Richard Bardos, said he had been assigned to the Odunayo Baba Oluwalade case but declined to comment further, referring to a Maryland law prohibiting lawyers from speaking about ongoing cases.

Jonathan Van Hoven, a lawyer for Mr. Williams, declined to comment. The Maryland District Attorney’s Office said Olakitan Oluwalade has not yet been assigned a lawyer.

“As the public searches for vaccines to protect themselves and their families from Covid-19, scammers wait to take advantage of their desperation,” said James R. Mancuso, a special agent for Homeland Security Investigations. “We want to remind the public to exercise extreme caution online, especially when it comes to Covid-19 vaccines, treatments and protective equipment.”

Categories
Business

Can’t Discover an N95 Masks? This Firm Has 30 Million That It Can’t Promote.

One year after the start of the pandemic, the disposable, virus-filtering N95 mask remains a sought-after protective device. The ongoing shortage has forced doctors and nurses to reuse their N95s, and common Americans have scoured the internet – mostly in vain – to get them.

But Luis Arguello Jr. has plenty of N95s for sale – 30 million of them made by his family-run company DemeTech in its factories in Miami. He just doesn’t seem to find buyers.

After the pandemic uncovered a huge need for protective equipment and China closed its inventory to the world, DemeTech, a medical suturing manufacturer, stepped into the mask business. The company invested tens of millions of dollars in new machines and then went through a nine-month approval process to make the masks marketable.

However, demand is so low that Mr Arguello is preparing to lay off some of the 1,300 workers he had hired to ramp up production.

“It’s crazy that we can’t get these masks to the people who need them badly,” he said.

In one of the more confusing divisions between supply and demand, many of the nearly two dozen small American companies that recently jumped into N95 manufacturing are facing the brink – they cannot crack the market despite the vows of both former presidents Donald Trump and President Biden is expected to “buy Americans” and boost domestic production of essential medical equipment.

These companies need to break through the ingrained buying habits of hospital systems, medical care distributors, and state governments. Many buyers are reluctant to try the new crop of American-made masks, which are often slightly more expensive than those made in China. Another obstacle is companies like Amazon, Facebook, and Google, which have banned the sale and promotion of N95 masks to prevent profiteers from diverting critical medical devices needed by frontline medical professionals.

According to public health experts and industry executives, an ambitious strategy that includes federal loans, subsidies and government purchasing guidelines is needed to ensure the long-term viability of a domestic industry that is vital to the national interest.

“The government needs to call outsourcing American mask supplies for what it is: a national safety issue,” said Mike Bowen, owner of Prestige Ameritech, a Texas mask maker who testified before Congress that domestic manufacturers need support .

Based on his experience during the 2009 swine flu pandemic, he said that many of the startups would likely not survive without systemic changes. “We’ve seen this movie before,” said Bowen, a 35-year industry veteran. “If and when the pandemic is over, it will be a bloody bloodbath.”

Domestic heavyweights like 3M and Honeywell ramped up N95 mask production last year, in part spurred on by the War Production Act during the war. However, the 120 million masks they produce in the US each month cannot meet the annual health sector needs of N95 3.5 billion. Most of the major players’ masks are forwarded to medical distributors who supply the major hospital systems in the country.

Smaller companies could help fill the gap. Together, 19 companies that recently received federal certification produce tens of millions of masks a month. Northwell Health, a large hospital chain, has used a total of 300,000 masks a month in its 23 hospitals.

Updated

Apr. 10, 2021, 2:55 p.m. ET

Companies include Protective Health Gear, a New Jersey start-up founded by a chiropractor and store manager who was struggling to find permanent customers, and ALG Health, a lighting company that manufactures 1.5 million masks a month in Bryan, Ohio. but cannot get the final investment required to meet the target of 30 million per month production.

Unlike his predecessor, Mr Biden has made face covering an important part of his plan to contain the pandemic. In one of his first acts as President, Mr. Biden directed federal agencies to aggressively use the Data Protection Agency to encourage domestic personal protective equipment manufacturing, and a subsequent executive order is designed to encourage government purchases of state goods. Still, none of the half-dozen startups interviewed for this article said they had been contacted by federal officials.

“I am encouraged by the first steps in the Biden administration,” said Scott Paul, president of the Alliance for American Manufacturing, an industry group. “But the federal government really needs to step up its game and reassure American companies that have responded to the national call to action, not just for this crisis but also for those of the future.”

Tim Manning, the White House’s Covid-19 supply coordinator, said the administration would announce a number of new DPA contracts for personal protective equipment in the coming weeks, but the bigger problems in the supply chain would take longer.

“One of our priorities in our pandemic response is to do this in such a way that we can make sure the industrial base expansion can be sustained so that we don’t end up in the same situation next time,” Manning said in an interview .

Companies like United States Mask, a Fort Worth, Texas start-up that began manufacturing N95 in November, may not hold out much longer. John Bielamowicz, a commercial real estate agent who started the company with a friend in the first few weeks of the pandemic, said he was frustrated with the lack of interest from hospital chains, long-term care facilities and local governments who buy in bulk.

Although the company’s masks have been certified by the National Institute for Safety and Health at Work, a division of the Centers for Disease Control and Prevention, many buyers are reluctant to try unfamiliar products, according to Bielamowicz. Large hospitals prefer to stick to masks they already use as it is time consuming to test new models on staff. However, many cost-conscious bulk buyers prefer to buy cheaper Chinese ones.

One of the more painful rejections came from Tarrant County, where Mr. Bielamowicz’s factory is located. Last month, the county disqualified its company’s offer because officials wanted to buy certain Chinese-made models. District officials did not respond to requests for comment.

“We got into this business because we were concerned about America’s reliance on foreign manufacturing and wanted to do something about it,” said Bielamowicz, whose masks sell for $ 2.25 apiece – pennies more than China’s manufactured. “Are we going to die on the vine if we make N95 at a competitive price?”

While hoping for Washington intervention, United States Mask and other N95 manufacturers said the ability to sell to the public through online retailers like Amazon would help them stay afloat.

Dr. Monica Gandhi, an infectious disease specialist at the University of California at San Francisco, said the vast majority of Americans who have embraced wearing masks and are concerned about new variations would eagerly upgrade to N95 or other types of virus filter masks when you were available.

“Right now, high filtration masks are more important than ever,” she said.

The problem is getting consumers to their retail websites. Right now, anyone trying to buy N95 masks on Google Shopping or Facebook Marketplace will be greeted with a blank page. On Amazon, a search for N95 leads to a multitude of vendors selling KN95 masks, a Chinese-made equivalent that researchers say is less effective.

Lance Brown, the managing director of Rhino Medical Supply, a South Carolina distributor, has been solely focused on selling N95s, which are made by the new generation of American entrepreneurs. Their masks, he said, are superior to most made in China, but his appeals to national pride often don’t push institutional buyers who are focused on the bottom line.

Mr Brown has also urged online retailers to reconsider their sweeping bans on N95 masks. The problem could easily be fixed by creating exemptions for government-certified masks.

“How come you can spread conspiracy theories on Facebook, but we can’t sell N95 masks to the millions of Americans who need them right now?” Asked Mr. Brown. “I can understand that Facebook doesn’t want to sell masks made by a man in their garage, but these masks meet strict NIOSH guidelines.”

Google and Facebook said they have no immediate plans to change their policies, which are based on guidelines from the CDC and the World Health Organization, to ensure that healthcare workers have adequate protective equipment. Amazon did not respond to requests for comments.

On the one hand, Mr. Bielamowicz discovered the advantages of a small public exhibition. Last month, when he and his partner were debating whether to throw in the towel, a local newspaper columnist wrote about their troubles. The company was instantly overwhelmed by orders from school nurses, cancer patients, and key staff, many of whom said they had given up looking for N95 masks.

Within three days, the company had sold out its entire inventory of 250,000 masks.